ImmunologyEMBO ReportsPeer-reviewed
Cholesterol Restriction Primes RIG-I Antiviral Responses Through a Noncanonical Type I IFN Pathway
Tasuku Nishimura, Takahisa Kouwaki, Ken Takashima…·Hiroyuki Oshiumi
This study shows that cholesterol restriction enhances RIG-I antiviral responses via a noncanonical type I IFN pathway, with implications for viral pandemic treatments.
12 citations